Sean Dodge
Stock Analyst at RBC Capital
(1.92)
# 3,125
Out of 4,944 analysts
133
Total ratings
30.21%
Success rate
-4.77%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $3.22 | +86.34% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $1.05 | +233.33% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $190.23 | +41.93% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.44 | +61.29% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $176.29 | +49.19% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $8.97 | +89.52% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $28.65 | +11.69% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $17.33 | -65.38% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $89.27 | +17.62% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $15.72 | +8.14% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $35.35 | -3.82% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $19.95 | -29.82% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $3.56 | +180.90% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.02 | +33.21% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $15.29 | -8.41% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $180.06 | -81.67% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $0.43 | +42,133.69% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $3.22
Upside: +86.34%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $1.05
Upside: +233.33%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $190.23
Upside: +41.93%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.44
Upside: +61.29%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $176.29
Upside: +49.19%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.97
Upside: +89.52%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $28.65
Upside: +11.69%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $17.33
Upside: -65.38%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $89.27
Upside: +17.62%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $15.72
Upside: +8.14%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $35.35
Upside: -3.82%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $19.95
Upside: -29.82%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $3.56
Upside: +180.90%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $21.02
Upside: +33.21%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $15.29
Upside: -8.41%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $180.06
Upside: -81.67%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $0.43
Upside: +42,133.69%